phenylalanine has been researched along with cardiovascular agents in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamski, J; Ala-Korpela, M; Artati, A; Casas, JP; Chaturvedi, N; Gaunt, TR; Gerszten, RE; Ghorbani, A; Havulinna, AS; Hughes, AD; Illig, T; Jula, A; Kähönen, M; Kaikkonen, J; Kangas, AJ; Kettunen, J; Lawlor, DA; Lehtimäki, T; Mikkilä, V; Perola, M; Prieto-Merino, D; Raitakari, OT; Ripatti, S; Salomaa, V; Sattar, N; Soininen, P; Tiainen, M; Tillin, T; Tynkkynen, T; Vasan, RS; Wang, Q; Wang, TJ; Würtz, P | 1 |
1 other study(ies) available for phenylalanine and cardiovascular agents
| Article | Year |
|---|---|
Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.
Topics: Adolescent; Adult; Age Distribution; Aged; Biomarkers; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Child; Comorbidity; Diabetes Mellitus; Docosahexaenoic Acids; Endophenotypes; Fatty Acids, Monounsaturated; Fatty Acids, Omega-6; Female; Finland; Health Surveys; High-Throughput Screening Assays; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Nuclear Magnetic Resonance, Biomolecular; Phenylalanine; Prospective Studies; Risk Assessment; Risk Factors; Sex Distribution; Smoking; United Kingdom; United States; Young Adult | 2015 |